YUPELRI
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
49502-806 -
Package NDC
49502-806-87 -
Package NDC
49502-806-93 -
Application number
NDA210598 -
SPL ID
b7b789a7-deb0-41d7-9c7d-e6cf68d1b893 -
SPL set ID
6dfebf04-7c90-436a-9b16-750d3c1ee0a6 -
UNII
G2AE2VE07O -
RxCUI
2102779 -
RxCUI
2102784
What the source publishes
- Labeler
- Viatris Specialty LLC
- Active ingredients
- revefenacin
- Form
- SOLUTION
- Routes
- RESPIRATORY (INHALATION)
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "YUPELRI",
"splId": "b7b789a7-deb0-41d7-9c7d-e6cf68d1b893",
"labels": [
{
"setId": "6dfebf04-7c90-436a-9b16-750d3c1ee0a6",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6dfebf04-7c90-436a-9b16-750d3c1ee0a6",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=6dfebf04-7c90-436a-9b16-750d3c1ee0a6"
}
],
"routes": [
"RESPIRATORY (INHALATION)"
],
"labeler": "Viatris Specialty LLC",
"finished": true,
"packaging": [
{
"sample": true,
"description": "7 POUCH in 1 CARTON (49502-806-87) / 1 VIAL, SINGLE-DOSE in 1 POUCH (49502-806-33) / 3 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "49502-806-87",
"identifierStatus": "well-formed",
"marketing_start_date": "20190101"
},
{
"sample": false,
"description": "30 POUCH in 1 CARTON (49502-806-93) / 1 VIAL, SINGLE-DOSE in 1 POUCH (49502-806-32) / 3 mL in 1 VIAL, SINGLE-DOSE",
"package_ndc": "49502-806-93",
"identifierStatus": "well-formed",
"marketing_start_date": "20181203"
}
],
"productId": "49502-806_b7b789a7-deb0-41d7-9c7d-e6cf68d1b893",
"useDomain": "unknown",
"dosageForm": "SOLUTION",
"productNdc": "49502-806",
"deaSchedule": null,
"genericName": "revefenacin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "REVEFENACIN",
"strength": "175 ug/3mL"
}
],
"applicationNumber": "NDA210598",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20181203",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175574",
"N0000175370"
],
"unii": [
"G2AE2VE07O"
],
"rxcui": [
"2102779",
"2102784"
],
"spl_set_id": [
"6dfebf04-7c90-436a-9b16-750d3c1ee0a6"
],
"pharm_class_epc": [
"Anticholinergic [EPC]"
],
"pharm_class_moa": [
"Cholinergic Antagonists [MoA]"
],
"manufacturer_name": [
"Viatris Specialty LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:49502-806_b7b789a7-deb0-41d7-9c7d-e6cf68d1b893"